1] Sigfrid L, Cevik M, Jesudason E, Lim WS, Rello J, Amuasi JH, et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study. BMJ Open. ( 2021 ) 11:e043887. doi: 10.1101/2020.08.26.20180950.
[2] Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. Sandra Lopez-Leon, Talia Wegman-Ostrosky, Carol Perelman, Rosalinda Sepulveda, Paulina A Rebolledo, Angelica Cuapio, Sonia Villapol; More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis.medRxiv : the preprint server for health sciences 2021 Jan 30; doi:10.1101/2021.01.27.21250617.
[3] Cheung OY, Chan JWM, Ng CK, Koo CK. The spectrum of pathological changes in severe acute respiratory syndrome ( SARS ) . Histopathology. 2004;45(2) :119-­124. 10.1111/j.1365-­2559.2004.01926.x.
[4] Lindsay T McDonald; Healing after COVID-19: are survivors at risk for pulmonary fibrosis?American journal of physiology. Lung cellular and molecular physiology 2021 02 01;320(2):L257-L265 doi:10.1152/ajplung.00238.2020.
[5] Fuzhou Wang, Richard M Kream, George B Stefano; Long-Term Respiratory and Neurological Sequelae of COVID-19.Medical science monitor : international medical journal of experimental and clinical research 2020 Nov 01;26:e928996 doi:10.12659/MSM.928996.
[6] Zhao X, Nicholls JM, Chen YG. Severe acute respiratory syndrome-­associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-­β signaling. J Biol Chem. 2008;283(6 ) :3272-­3280. 10.1074/jbc.M708033200.
[7] Lal SK. Molecular biology of the SARS-­coronavirus. Springer. 2010:1-­ 328. 10.1007/978-­3-­642-­03683-­5.
[8] Qiuyue Long, Jiwei Li, Xiaoyi Hu, Yangyuyan Bai, Yali Zheng, Zhancheng Gao; Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis.Frontiers in medicine 2021;8:702635 doi:10.3389/fmed.2021.702635.
[9] Balasubramanian A, MacIntyre NR, Henderson RJ, et al. Diffusing capacity of carbon monoxide in assessment of COPD. CHEST. 2019;156:1111–1119.
[10] Gattinoni L, Marini JJ, Busana M, Chiumello D, Camporota L. Spontaneous breathing, transpulmonary pressure and mathemat- ical trickery. Ann Intens Care. 2020;10(1) :1-­2. 10.1186/s13613-­020-­ 00708-­1.
[11] Tobin MJ, Laghi F, Jubran A. Caution about early intubation and mechanical ventilation in COVID-­19. Ann Intens Care. 2020;10(1) :4-­ 6. doi:10.1186/s13613-­020-­00692-­6.
[12] Clinical management of severe acute respiratory infection when COVID-19 is suspected.Released by World Health Organization on 13 March 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory- infection-when-novel-coronavirus-( ncov )-infection-is- suspected.
[13] General Office of National Health Commission of the People’s Republic of China. Office of National Administration of Traditional Chinese Medicine. Diagnosis and treatment of corona virus disease-19 ( 8th trial edition ) [J]. China Medicine, 2020, 15( 10 ) :1494-1499.(in Chinese ).
[14] Jin Meiling, Song Yuanlin, Zheng Jinping, et al.Guideline for pulmonary function testing in primary care ( 2018 ) , Chinese Journal of General Practitioners, 2019,18(6) : 511-518.
[15] Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med 2019;200( 8 ) :e70–88.
[16] Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology 2010;15( 3 ) :543–50.
[17] D S Hui, G M Joynt, K T Wong, C D Gomersall, et al; Impact of severe acute respiratory syndrome ( SARS ) on pulmonary function, functional capacity and quality of life in a cohort of survivors.Thorax 2005 May;60( 5 ) :401-9 doi:10.1136/thx.2004.030205.
[18] Lixin Xie, Youning Liu, Yueyong Xiao, et al; Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge.Chest 2005 Jun;127( 6 ) :2119-24 doi:10.1378/chest.127.6.2119.
[19] Jenny C Ngai, Fanny W Ko, Susanna S Ng, et al; The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status.Respirology ( Carlton, Vic. ) 2010 Apr;15( 3 ) :543-50 doi:10.1111/j.1440-1843.2010.01720.x.
[20] Wan Beom Park, Kang Il Jun, Gayeon Kim, Jae-Phil Choi,et al; Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome.Journal of Korean medical science 2018 Jun 11;33( 24 ) :e169 doi:10.3346/jkms.2018.33.e169.
[21] Svander Sarvan der Brugge, Stalman, Ljm Boonmande Winter, et al; Pulmonary function and health-related quality of life after COVID-19 pneumonia.Respiratory medicine 2021 01;176:106272 doi:10.1016/j.rmed.2020.106272.
[22] Tori Vigeland Lerum, Trond Mogens Aaløkken, Eivind Bronstad, et al; Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19.The European respiratory journal 2021 Apr;57( 4 ) doi:10.1183/13993003.03448-2020
[23] Xiaoneng Mo, Wenhua Jian, Zhuquan Su,et al; Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.The European respiratory journal 2020 Jun;55(6) doi:10.1183/13993003.01217-2020.
[24] Sabina A Guler, Lukas Ebner, Catherine Aubry-Beigelman, et al; Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study.The European respiratory journal 2021 04;57(4) doi:10.1183/13993003.03690-2020.
[25] Chaolin Huang, Lixue Huang, Yeming Wang, et al; 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.Lancet (London, England) 2021 01 16;397(10270):220-232 doi:10.1016/S0140-6736(20)32656-8.
[26] Xiaojun Wu, Xiaofan Liu, Yilu Zhou, et al; 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.The Lancet. Respiratory medicine 2021 07;9(7):747-754 doi:10.1016/S2213-2600(21)00174-0.
[27] Lixue Huang, Qun Yao, Xiaoying Gu, et al; 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.Lancet (London, England) 2021 08 28;398(10302):747-758 doi:10.1016/S0140-6736(21)01755-4.
[28] Yuhui Wang, Chengjun Dong, Yue Hu,et al; Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.Radiology 2020 08;296(2 ) :E55-E64 doi:10.1148/radiol.2020200843.
[29] Dai H, Zhang X, Xia J, etc. High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China. Int. J. Infect. Dis. 2020; 95: 106–112.
[30] Wang Y, Dong C, Hu Y, etc. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology 2020; 200843.
[31] Zhe Xu, Lei Shi, Yijin Wang, et al; Pathological findings of COVID-19 associated with acute respiratory distress syndrome.The Lancet. Respiratory medicine 2020 04;8(4):420-422 doi:10.1016/S2213-2600(20)30076-X.
[32] YuMiao Zhao, YaoMin Shang, Wen-Bin Song, etc; Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery.EClinicalMedicine 2020 Aug;25:100463 doi:10.1016/j.eclinm.2020.100463.
[33] Zhaohai Zheng, Fang Peng, Buyun Xu, et al; Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.The Journal of infection 2020 08;81(2):e16-e25 doi:10.1016/j.jinf.2020.04.021.
[34] J Zhang, X Wang, X Jia,et al; Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2020 Jun;26( 6 ) :767-772 doi:10.1016/j.cmi.2020.04.012.
[35] Haoming Zhu, Gaojing Qu, Hui Yu, Guoxin Huang, Lei Chen, Meiling Zhang, Shanshan Wan, Bin Pei; Features of α-HBDH in COVID-19 patients: A cohort study.Journal of clinical laboratory analysis 2021 Jan;35(1 ) :e23690 doi:10.1002/jcla.23690.
[36] Huiping Yan, Yufen Tan, et al; A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome ( SARS ) coronavirus in patients with SARS.Zhonghua Jiehe Zazhi 2006 Nov;45( 11 ) :896-9.
[37] Cesheng Li, Ding Yu, Xiao Wu,et al; Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.Nature communications 2021 07 06;12( 1 ) :4144 doi:10.1038/s41467-021-24230-5.
[38] Baweleta Isho, Kento T Abe, Michelle Zuo, etc.Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.Science immunology 2020 10 08;5( 52 ) doi:10.1126/sciimmunol.abe5511.
[37] Cesheng Li, Ding Yu, Xiao Wu, Hong Liang, et al; Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.Nature communications 2021 07 06;12( 1 ) :4144 doi:10.1038/s41467-021-24230-5.